Drug Type Small molecule drug |
Synonyms Thiothixene dihydrochloride dihydrate, Thiothixene hydrochloride (USP), Tiotixene dihydrochloride + [2] |
Mechanism 5-HT2A receptor antagonists(Serotonin 2a (5-HT2a) receptor antagonists), D1 receptor antagonists(Dopamine D1 receptor antagonists), D2 receptor antagonists(Dopamine D2 receptor antagonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseWithdrawn |
First Approval Date US (06 Apr 1970), |
Regulation- |
Molecular FormulaC23H31Cl2N3O2S2 |
InChIKeySSRKPUYBAUMQED-INHJUQNSSA-N |
CAS Registry49746-04-5 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D02612 | Thiothixene Hydrochloride | - |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Schizophrenia | US | 06 Apr 1970 |